Adline Chem Lab Ltd (524604)
Latest quarterly results (Q4 FY26)
In its latest reported quarter, Q4 FY26, Adline Chem's revenue was ₹0.0 Cr, and net profit ₹-0.1 Cr (against a profit a year earlier).
| Q4 FY26 (₹ Cr) | Value | YoY vs Q4 FY25 | QoQ |
|---|---|---|---|
| Revenue | ₹0.0 | — | — |
| Operating profit | ₹-0.1 | loss widened | loss widened |
| Net profit | ₹-0.1 | to loss | loss widened |
| EPS (₹) | -0.15 | to loss | loss widened |
📢 Recent Corporate Announcements
Adline Chem Lab has approved the convening of its 38th Annual General Meeting (AGM) on Monday, September 28, 2026, via Video Conferencing. The cut-off date for remote e-voting eligibility has been set for September 21, 2026, with voting open from September 25 to September 27, 2026. The Board approved the appointment of Mrs. Anita Ganeshbhai Marvadi as an Additional Non-Executive Independent Director, subject to shareholder regularisation for a 5-year term. Additionally, the company noted and paid a minor fine of Rs 1,180 levied by BSE for delayed compliance under Regulation 6(1).
- 38th Annual General Meeting convened for September 28, 2026, at 2:00 PM IST via VC/OAVM
- Cut-off date for e-voting eligibility fixed as September 21, 2026; remote e-voting window runs September 25-27, 2026
- Mrs. Anita Ganeshbhai Marvadi appointed as Non-Executive Independent Director for a proposed 5-year term
- Noted and paid Rs 1,180 penalty levied by BSE for delayed compliance under LODR Regulation 6(1)
Adline Chem Lab Limited has scheduled a Board of Directors meeting on August 27, 2026. The board will consider and approve the Draft Notice, Director's Report, and schedule for the 38th Annual General Meeting (AGM) for the financial year ended March 31, 2026. Additionally, the board will consider the appointment of Mrs. Anita Ganeshbhai Marvadi as an Additional Non-Executive Independent Director, subject to shareholder approval. Key procedural dates including the Book Closure and e-voting record date will also be determined.
- Board meeting scheduled for Thursday, August 27, 2026
- AGM notice and Directors' Report for the financial year ended March 31, 2026, to be finalized
- Proposal to appoint Mrs. Anita Ganeshbhai Marvadi (DIN: 11808366) as Additional Non-Executive Independent Director
- Dates for Book Closure and e-voting cut-off/record date to be fixed
Adline Chem Lab reported a net profit of Rs 4.01 Lakh for the quarter ended June 30, 2026, marking a turnaround from a loss of Rs 5.13 Lakh in the year-ago period. However, the company continues to report zero revenue from operations, with the entire income of Rs 11.99 Lakh coming from 'Other Income'. Expenses for the quarter stood at Rs 8.80 Lakh, which notably included a Rs 1.06 Lakh penalty from the BSE for failing to appoint a Company Secretary. The company remains a micro-cap with a negative net worth of approximately Rs 2 Cr and no active core business revenue.
- Net Profit of Rs 4.01 Lakh in Q1 FY27 compared to a loss of Rs 5.13 Lakh in Q1 FY26
- Revenue from operations remained at Rs 0.00 for the fifth consecutive quarter
- Other Income of Rs 11.99 Lakh was the sole source of total income for the period
- BSE imposed a penalty of Rs 1.06 Lakh for non-appointment of a Company Secretary
- Finance costs stood at Rs 4.84 Lakh, representing over 50% of total quarterly expenses
Adline Chem Lab reported a marginal net profit of ₹4.01 Lakhs for Q1 FY27, a turnaround from a loss of ₹9.26 Lakhs in the previous quarter. However, the company continues to report zero revenue from operations, with its total income of ₹11.99 Lakhs derived entirely from 'Other Income'. Total expenses decreased to ₹8.80 Lakhs from ₹11.72 Lakhs sequentially, though this includes a ₹1.06 Lakhs penalty for regulatory non-compliance. The company remains financially stressed with a negative net worth of ₹-2 Cr and no core business activity.
- Net Profit of ₹4.01 Lakhs in Q1 FY27 compared to a loss of ₹9.26 Lakhs in Q4 FY26
- Revenue from operations remained at ₹0.00, consistent with the previous four quarters
- Other Income increased significantly to ₹11.99 Lakhs from ₹1.15 Lakhs in the preceding quarter
- Finance costs of ₹4.84 Lakhs accounted for 55% of the total quarterly expenditure
- BSE imposed a penalty of ₹1.06 Lakhs during the quarter for the non-appointment of a Company Secretary
Adline Chem Lab Ltd has scheduled a board meeting for August 13, 2026, to consider and approve its unaudited standalone financial results for the quarter ended June 30, 2026. The company is currently a micro-cap entity with a market capitalization of just Rs 8 Cr and reported zero revenue for the trailing twelve months (TTM). With a negative net worth of Rs -2 Cr and persistent losses, the upcoming results are critical to assess any potential business activity. The trading window for designated persons has been closed since July 1, 2026.
- Board meeting scheduled for August 13, 2026, to approve Q1 FY27 results.
- Trading window closed from July 1, 2026, until 48 hours post-announcement.
- Company reported zero revenue (Rs 0 Cr) for the entire FY26 and TTM period.
- Net worth stands at a negative Rs -2 Cr as per latest available data.
- Promoter holding has decreased from 29.61% in Sep 2025 to 25.85% in Mar 2026.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.